• NEWS RELEASE                                                                                                 Contacts:                                                                                                 Victor Rocha                                   Ryan Weispfenning                                                                                                 Public Relations                            Investor Relations                                                                                                 +1-901-399-2401                     +1-763-505-4626 FOR IMMEDIATE RELEASE ... Learn More


  • Submitted on: Oct 06, 2020, by Stryker (#1011)

    Stryker to showcase new Bone Vac autologous bone dust collector at the North American Spine Society annual meeting Kalamazoo, Michigan, USA – October 6, 2020 – Stryker will showcase its new Bone Vac autologous bone dust collector at the North American Spine Society (NASS) meeting taking place... Learn More

  • DALLAS, Feb. 12, 2020 /PRNewswire/ -- 4WEB Medical, an orthopedic device company focused on developing innovative implants with an Advanced Structural Design that utilizes its proprietary Truss Implant Technology™, announced today that the company achieved record revenues in 2019.  Additionally, in Q4 2019, 4WEB recorded the company's largest quarterly revenue to date.  ... Learn More

  • Isto Biologics, the Orthobiologics Pioneers, Named 2020 Top Orthopedic Solution Provider HOPKINTON, Mass., April 13, 2020 (Newswire.com) - Isto Biologics, a leading orthobiologics company focused on helping patients heal faster, has just been named a 2020 Top 10 Orthopedic Solution Provider by MedTech Outlook for exhibiting innovative technologies and strategies... Learn More

  • Leesburg, Va.—Oct. 5, 2020—Stryker announced today that it has surpassed one million Mesa Pedicle Screw implantations globally since its launch in 2006. To celebrate this milestone, Stryker will feature the Mesa Spinal System in a virtual exhibit space during the North American Spine Society (NASS) Annual Meeting, occurring virtually from... Learn More

  • Spineart completed an in vivo study on sheep to evaluate its proprietary Ti-LIFE Technology under physiological conditions.  At one spinal level, Ti-LIFE cages were implanted without bone graft or biological materials.  At another spinal level, PEEK cages were implanted with morselized iliac crest autograft. The Ti-LIFE interbody cages displayed quick... Learn More

  • Karlsruhe (GER) — joimax®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, held its first online global symposium, “Endoscopic Spine Surgery – Indications, Technology and Limitations”, at its headquarters in the Training and Education Center (TEC) in Karlsruhe-Germany, on April 24-25, 2020. In... Learn More

  • ATLANTA, September 15, 2020 – ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for ControlRad Trace use on OEC 9900 Mobile C-arms.  “This additional FDA clearance... Learn More

  • Karlsruhe (GER) – joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new partnership with Australian medical device distributor, LifeHealthcare. The two companies have entered into a long-term relationship to provide a broader surgical choice for patients considering... Learn More

  • News Release       Contact: Mahesh Krishnan VP, Sales and Marketing, MiRus mkrishnan@mirusmed.com 770-317-5564 First Spine Surgeries Using The MoRe® Superalloy ATLANTA — August 30, 2019— MiRus announces successful spine surgeries at several centers across the... Learn More

  • WILMINGTON, Mass.--(BUSINESS WIRE)--Apr. 29, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Citoxlab for €448 million in cash (or approximately $500 million based on current exchange rates), subject to customary closing adjustments. Citoxlab is a premier, non-clinical contract research organization... Learn More